New England Securities’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
$743K Sell
25,135
-1,985
-7% -$56.9K 0.26% 99
2014
Q3
$761K Buy
27,120
+1,394
+5% +$39.1K 0.27% 93
2014
Q2
$724K Buy
25,726
+6,689
+35% +$191K 0.25% 102
2014
Q1
$580K Buy
19,037
+3,134
+20% +$93.4K 0.22% 116
2013
Q4
$462K Sell
15,903
-969
-6% -$28.2K 0.19% 145
2013
Q3
$460K Buy
16,872
+736
+5% +$20K 0.23% 115
2013
Q2
$429K Buy
+16,136
New +$446K 0.29% 82

Other funds holding PFE

New England Securities's PFE Position: Q4 2014 in Review

New England Securities reduced its Pfizer (PFE) stake by 7.3% in Q4 2014, selling an estimated $56.9K and leaving 25,135 shares worth $743K. The position accounts for 0.26% of the portfolio, ranked #99.

New England Securities first reported a position in PFE in Q2 2013 and has held it in 7 quarters since. The position peaked at $761K in Q3 2014. 1,860 funds tracked by Wall St. Rank hold PFE as of Q4 2014.

  • New England Securities held 25,135 shares of Pfizer worth $743K as of Q4 2014.
  • New England Securities sold 1,985 Pfizer shares in Q4 2014, an estimated $56.9K.
  • Pfizer made up 0.26% of New England Securities's portfolio in Q4 2014, its #99 holding.
  • New England Securities first reported a position in Pfizer in Q2 2013 and has held it in 7 quarters since.
  • New England Securities's Pfizer position peaked at $761K in Q3 2014.
  • 1,860 funds tracked by Wall St. Rank held Pfizer as of Q4 2014.

Based on New England Securities's 13F filing for Q4 2014, filed 26 Jan 2015.